From TT:
We will shortly be reporting the first morning session of day 6 of evidence of Redvers v NHS Sussex Integrated Care Board & Mr Adam Doyle at Croydon Employment Tribunal. Mr Doyle remains on the witness stand and we are due to resume at 10am. t.co/N6CSEtmdEY
Dr Redvers, a named GP safeguarding lead, has a constructive dismissal case. Clinical concerns were raised about a specific doctor at WellBN, a Brighton GP practice. She claims that as a result of escalating those claims from 2020 onwards, she was constructively dismissed.
Her legal claim is discrimination on the grounds of her employer’s perception she had gender critical beliefs and on the grounds of her protected belief in evidence-based medicine (EBM). The respondent defends the latter claim by pleading that EBM is just an opinion.
Earlier coverage of this hearing can be found on our Substack at:
t.co/TwXeLCDnpt
We are a collective of unpaid volunteers. Please consider subscribing to our Substack to support our legal, digital and some travel costs.
We report what we hear in good faith but do not provide a verbatim transcript of the hearing.
Abbreviations:
J - Judge Katherine Andrews (sitting alone)
DR/C - Doctor Sarah Redvers, claimant
CM/RB - Chris Milsom, claimant barrister
CE/RB - Charlotte Elves, Claimant Barrister
PD - Peter Daly, solicitor for the C
NHSSICB/R1 - NHS Sussex Integrated Care Board, first respondent
AD/R2 - Adam Doyle, second respondent, CEO of R1 2019-2025
Rs - collectively the respondents
RB/BW - Ben Williams, Respondent's barrister
EBM - Evidence-based medicine
SG - Safeguarding
WB - WellBN, Brighton based GP practice
GC - Gender Critical or sex realist beliefs
GI - Gender Identity belief
WS - Witness Statement
Ix - investigation
Gx - grievance
Cx - complaint
SH/DSH - Dr Sam Hall, GP at WellBN, Trustee - the Clare Project (TCP), Clinical Lead - Trans Health Hub, GIC Partner - Trans Health Improvement Board at R1, trans-identified female
DA - Dusty Amroliwala, ext consultant, investigated complaint filed by DSH against C
LB - Lola Banjoko, Exec Managing Director, chair of Trans Health Improvement Board, advised R1 on trans matters
NC - Nikky Cambridge, former trustee of TCP
AC - Allison Cannon, Chief Nursing Officer, R1, tasked w implementing the recommendations of the 1st grievance outcome
CCD - Dr Claire Cochrane-Dyet, Dep Medical Director for System Improvement & Professional Standards, NHSE, commissioned Warshafsky Report
HD - Dr Hannah Davies, Deputy Chief Medical Office, R1
SD - Samantha Durrant, Lay vice chair until July 2022, 1st grievance manager
NE - Naomi Ellis, dep director of Safeguarding, R1
MF - Dr Mary Flynn, Named GP for Safeguarding, also filed g/x in relation to Amroliwala Report
PF - Pennie Ford, Executive Managing Director, R1, 2nd grievance manager
EG - Dr Elizabeth Gill, Chief Medical Officer, R1
HH - Hannah Hamilton, Chief financial officer, R1, 2nd grievance appeal manager
BJ - Dr Becky Jarvis, clinical lead for mental health, R1
TM - Tom Micklewright, managing partner of Lime Tree Surgery
IM - Ian Mundy, HR Consultant, Your Consultancy, 1st grievance investigator
MP - Mark Power, interim Chief People Officer (until April 2022), R1, managed Amroliwala investigation
RR - Dr Rebecca Richards, GP partner, Lime Tree Surgery, raised concerns to C about SH
AR - Anne Robson, Interim Chief People Officer (April -August 2022), R1
DS - Dr Dinesh Sinha, Chief Medical Officer (June 2022 - April 2024), Chair of Trans Health Improvement Board (THIB)
MS - Mark Smith, Chief People Officer, R1 (Aug 2022 - Jan 2025) Acting CEO (Jan 2025 - June 2025) Deputy CEO & Director of Transition (June 2025 - present)
RW - Dr Robin Warshafsky, GP NHSE, Author of Warshafsky Report (WR)